BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Alcohol
,
Lipitor
,
rs7903146
,
IGF1
,
Fatty acid metabolic process
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neuroprotective drug
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
NF639 with EGCG-resistance expression profiling
Leukocytes of Kawasaki disease patients prior to and after IgG and methylprednisolone therapy
Broad Connectivity Map (CMAP 2.0) compound database
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Explore Curated Studies Results
Literature
Most Relevant Literature
Neuroprotectants in the Era of Reperfusion Therapy.
Using lithium as a neuroprotective agent in patients with cancer.
NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restor…
Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.
Neuroprotectants attenuate hypobaric hypoxia-induced brain injuries in cynomolgus monkeys.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Di…
Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After…
Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Bra…
Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ